Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Formestane, formerly sold under the brand name Lentaron among others, is a steroidal, selective aromatase inhibitor which is used in the treatment of estrogen receptor-positive breast cancer in postmenopausal women. The drug is not active orally, and was available only as an intramuscular depot injection. Formestane was not approved by the United States…
Measurement, Overview & Chemistry
Explore the main themes, entities and connections around Formestane. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used aromatase inhibitor active synthesis androstenedione name lentaron others drug intramuscular injection addition 17-dione steroidal selective postmenopausal analogue prohormones 4-hydroxytestosterone
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Formestane | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Formestane | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Formestane | ATC code | L02BG02 (WHO) | 1.00 | infobox |
| Formestane | CAS Number | 566-48-3 Y | 1.00 | infobox |
| Formestane | ChEBI | CHEBI:75172 N | 1.00 | infobox |
| Formestane | ChEMBL | ChEMBL132530 Y | 1.00 | infobox |
| Formestane | ChemSpider | 10799 Y | 1.00 | infobox |
| Formestane | CompTox Dashboard (EPA) | DTXSID3034113 | 1.00 | infobox |
| Formestane | Drug class | Aromatase inhibitor; Antiestrogen | 1.00 | infobox |
| Formestane | ECHA InfoCard | 100.153.838 | 1.00 | infobox |
| Formestane | Formula | C19H26O3 | 1.00 | infobox |
| Formestane | KEGG | D07260 Y | 1.00 | infobox |
| Formestane | Molar mass | 302.414 g·mol−1 | 1.00 | infobox |
| Formestane | Other names | 4-Hydroxyandrost-4-ene-3,17-dione | 1.00 | infobox |
| Formestane | PubChem CID | 11273 | 1.00 | infobox |
| Formestane | Routes of administration | Intramuscular injection | 1.00 | infobox |
| Formestane | Trade names | Lentaron, others | 1.00 | infobox |
| Formestane | UNII | PUB9T8T355 | 1.00 | infobox |
| Formestane | is a | analogue of androstenedione.Formestane is often used to suppress the production of estrogens from anabolic steroids or prohormones | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.